Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,957 | 2,205 | 99.7% |
| Education | $54.23 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,924 | 126 | $0 (2023) |
| Novo Nordisk Inc | $1,972 | 249 | $0 (2022) |
| Lilly USA, LLC | $1,525 | 202 | $0 (2022) |
| ABBVIE INC. | $1,334 | 142 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,295 | 164 | $0 (2022) |
| PFIZER INC. | $1,273 | 157 | $0 (2023) |
| Allergan, Inc. | $1,092 | 123 | $0 (2022) |
| Merck Sharp & Dohme LLC | $1,023 | 102 | $0 (2023) |
| Amarin Pharma Inc. | $927.27 | 100 | $0 (2022) |
| Amgen Inc. | $901.35 | 97 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $304.06 | 15 | AstraZeneca Pharmaceuticals LP ($148.21) |
| 2022 | $2,903 | 258 | AstraZeneca Pharmaceuticals LP ($586.75) |
| 2021 | $3,259 | 309 | AbbVie Inc. ($657.99) |
| 2020 | $2,794 | 284 | AstraZeneca Pharmaceuticals LP ($578.23) |
| 2019 | $3,535 | 422 | Novo Nordisk Inc ($449.84) |
| 2018 | $3,780 | 468 | Allergan Inc. ($360.36) |
| 2017 | $4,436 | 456 | Janssen Pharmaceuticals, Inc ($524.96) |
All Payment Transactions
2,212 individual payment records from CMS Open Payments — Page 1 of 89
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/17/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Cardiovascular | ||||||
| 08/11/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Cardio-renal | ||||||
| 03/15/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Inflammation | ||||||
| 03/13/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.59 | General |
| 03/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Oncology | ||||||
| 02/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Oncology | ||||||
| 02/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/10/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/30/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: VACCINES | ||||||
| 01/09/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Respiratory | ||||||
| 01/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BREZTRI | Food and Beverage | In-kind items and services | $88.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/30/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Diabetes | ||||||
| 12/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardio-renal | ||||||
| 12/21/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Cardio-renal | ||||||
| 12/15/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Diabetes | ||||||
| 12/14/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.44 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 146 | 172 | $57,090 | $9,369 |
| 2022 | 14 | 936 | 1,321 | $317,240 | $93,354 |
| 2021 | 14 | 1,372 | 1,880 | $296,605 | $97,675 |
| 2020 | 15 | 1,583 | 2,354 | $275,315 | $140,370 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 130 | $46,800 | $7,162 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 42 | $10,290 | $2,207 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 267 | 494 | $177,840 | $46,364 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 195 | 344 | $84,280 | $21,926 | 26.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 65 | 65 | $24,700 | $9,560 | 38.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 110 | 110 | $9,900 | $7,539 | 76.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 82 | 82 | $4,100 | $2,763 | 67.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 25 | 27 | $2,700 | $1,364 | 50.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 15 | $2,250 | $738.46 | 32.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 17 | 17 | $2,550 | $675.26 | 26.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 30 | 30 | $1,800 | $632.50 | 35.1% |
| 90471 | Administration of vaccine | Office | 2022 | 41 | 41 | $3,485 | $622.79 | 17.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 41 | 42 | $2,310 | $430.08 | 18.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 12 | 12 | $600.00 | $379.56 | 63.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 18 | 19 | $380.00 | $310.73 | 81.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 20 | 23 | $345.00 | $48.92 | 14.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 227 | 552 | $101,155 | $29,645 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 282 | 431 | $98,505 | $26,176 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 172 | 172 | $37,240 | $11,663 | 31.3% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 146 | 146 | $10,330 | $9,528 | 92.2% |
| 80502 | Comprehensive, clinical pathology consultation | Office | 2021 | 173 | 176 | $21,120 | $7,724 | 36.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 182 | 182 | $9,100 | $3,535 | 38.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 17 | 17 | $2,550 | $2,123 | 83.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 11 | 11 | $3,520 | $2,073 | 58.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 29 | 29 | $2,505 | $1,893 | 75.6% |
About Dr. Eugene Hrabarchuk, MD
Dr. Eugene Hrabarchuk, MD is a General Practice healthcare provider based in Franklin, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396704938.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Hrabarchuk, MD has received a total of $21,011 in payments from pharmaceutical and medical device companies, with $304.06 received in 2023. These payments were reported across 2,212 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($20,957).
As a Medicare-enrolled provider, Hrabarchuk has provided services to 4,037 Medicare beneficiaries, totaling 5,727 services with total Medicare billing of $340,768. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Franklin, NJ
- Active Since 03/22/2006
- Last Updated 07/08/2007
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1396704938
Products in Payments
- FARXIGA (Drug) $1,265
- VRAYLAR (Drug) $1,089
- Vascepa (Drug) $927.27
- Ozempic (Drug) $912.91
- JARDIANCE (Drug) $733.95
- CHANTIX (Drug) $733.75
- SYMBICORT (Drug) $704.71
- LORZONE (Drug) $574.16
- STIOLTO RESPIMAT (Drug) $521.53
- INVOKANA (Drug) $520.83
- ENTRESTO (Drug) $520.63
- JANUVIA (Drug) $498.14
- Livalo (Drug) $454.61
- EMGALITY (Drug) $450.34
- Aimovig (Biological) $429.91
- TRULICITY (Drug) $421.40
- UBRELVY (Drug) $391.31
- Saxenda (Drug) $385.68
- Kerendia (Drug) $344.77
- Prolia (Biological) $322.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Franklin
Tracy Nelson, Apnp, APNP
General Practice — Payments: $22,140
Dr. Amber Johnson, D.d.s, D.D.S
General Practice — Payments: $4,624
Mr. Charles Mack, D.d.s, D.D.S
General Practice — Payments: $3,074
Mr. Sean Rayment, Dmd Dsc, DMD DSC
General Practice — Payments: $2,727
Dr. Susan Chmiel, Dds, DDS
General Practice — Payments: $1,905
Dr. Andretta Porter-Williams, Dds, DDS
General Practice — Payments: $1,850